Democrats Are About to Give Big Pharma the Big Tobacco Treatment
The House of Representatives' first oversight hearing of 2019 wasn't about Trump. It was about skyrocketing drug prices.
The House of Representatives' first oversight hearing of 2019 wasn't about Trump. It was about skyrocketing drug prices.
The government has less flexibility to address a financial crisis than it did during the last one.
The president of the New York Federal Reserve is resigning, and Democrats are pushing for diversity in his replacement.
The bipartisan push to roll back parts of Dodd-Frank reveals a minority party that can’t get it right on the policy or the politics.
Republicans are on the verge of attaining a long-coveted prize—with the assistance of Senate Democrats who have ties to the financial industry.
A federal court ruled that the Consumer Financial Protection Bureau is constitutional, but the case appears headed to the Supreme Court.
How Republicans undid so many of his accomplishments in a single year
Why is a so-called populist trying to dismantle America's most effective consumer watchdog?
The president's early policies benefit corporations and the rich at the expense of everyday Americans.
Political scientists have argued that Trump represents the last gasp of a failing coalition. But we might be in a new political era altogether.
Dodd-Frank left it to regulators and judicial activists to make the rules for systemically important financial institutions. And now MetLife is off the hook.
He accuses critics of cynicism, without recognizing that he bears blame.
This is how big business fights government regulations—from the inside.
Bernie Sanders and Hillary Clinton don't agree on financial reform. Whose side will voters take?
And, for once, the commission is not letting them get away with it